Progesterone: all 270 studies that test it

Page 2 of 3. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• The Role of Hormones in Postpartum Mood DisordersCompletedNCT00001481Phase 2Results posted
• The Effects of Reproductive Hormones on Mood and BehaviorCompletedNCT00001322Phase 1/2Results posted
• Oral Nifedipine vs Vaginal Progesterone for Prolonging Pregnancy in Preterm LaborCompletedNCT07865949Phase 4
• Threatened Preterm Labour: Vaginal Progesterone Versus NifedipineCompletedNCT07649668Phase 4
• Effect of Vaginal Progesterone Treatment on Pregnancy and Newborn Outcomes in Women With Preterm LaborCompletedNCT07523295Phase 4
• Intramuscular vs Rectal Progesterone in Preventing Preterm Labour After Cervical CerclageCompletedNCT07307092Not applicable
• Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)CompletedNCT07173361Phase 1
• Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm BirthCompletedNCT06975943Not applicable
• Endometrial Transcript Profile with Progesterone After Post-ovulatory MifepristoneCompletedNCT06616077Early Phase 1
• Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.SuspendedNCT05980091Phase 1
• Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.CompletedNCT05954962Phase 4
• Rescue Progesterone Supplementation During Frozen Embryo TransferSuspendedNCT05555121Phase 2
• HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy LossWithdrawnNCT05365464Phase 2
• Clinical and Basic Researches Related to ZhenQi Buxue Oral Liquid in Treating Menstrual DisordersStatus unknownNCT05312190Not applicable
• Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase SupportCompletedNCT05276531Not applicable
• Sexual Intercourse and Vaginal Absorption of ProgesteroneCompletedNCT05232344Not applicable
• Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer CyclesCompletedNCT05189145Not applicable
• Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female SubjectsCompletedNCT05125640Phase 1
• Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal RouteCompletedNCT05125627Phase 1
• Natural Progesterone for the Treatment of Recurrent GlioblastomaTerminatedNCT05091866Early Phase 1
• Progesterone Action on Endometrium of PCOSCompletedNCT05062135Not applicable
• Prediction and Prevention of Twin Premature Birth 2021Status unknownNCT05061641Phase 4
• Estradiol and Progesterone Levels Following Frozen Embryo TransferCompletedNCT04997525Phase 4
• A Randomized Controlled Study of Prolonging the Time of Progesterone Supplementation to Improve the Pregnancy Outcome of Single Day 6 Blastocyst Transfer of Freeze-thaw CycleStatus unknownNCT04938011Phase 2
• Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycleCompletedNCT04846218Not applicable
• Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High RespondersStatus unknownNCT04797338Phase 4
• Pharmacokinetics of Progesterone in Pregnancy-2TerminatedNCT04753957Phase 1
• Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin PregnanciesCompletedNCT04748562Phase 4
• Novel Approaches for Minimizing Drug-Induced QT Interval LengtheningCompletedNCT04675788Phase 4
• Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity ParametersCompletedNCT04499131Phase 4
• Effect of Progesterone Therapy on Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial DopplerStatus unknownNCT04426487Early Phase 1
• Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian ResponseCompletedNCT04414761Phase 3
• Progesterone for the Treatment of COVID-19 in Hospitalized MenCompletedNCT04365127Phase 1
• Comparison Between Vaginal Pessary and Progestogen in Twin Pregnancy With Short Cervical LengthCompletedNCT04342585Phase 3
• Pessary Versus Progesterone in SingletonsStatus unknownNCT04300322Not applicable
• Serum Progesterone on the Day of Thawed Embryo Transfer and Pregnancy Rate After an Artificial Endometrial PreparationCompletedNCT04278508Not applicable
• Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age FetusesCompletedNCT04161989Not applicable
• Progesterone in the Treatment of Acute Hemorrhagic StrokeStatus unknownNCT04143880Phase 4
• Progesterone and Resting Energy ExpenditureTerminatedNCT04140968Phase 4
• Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.CompletedNCT04108039Not applicable
• Progesterone Versus Progesterone Plus Dydrogesterone in FETCompletedNCT03998761Not applicable
• Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial HyperplasiaCompletedNCT03992937Not applicable
• Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT PatientsTerminatedNCT03976544Phase 4
• Progesterone Supplementation in Threatened AbortionCompletedNCT03930212Phase 4
• Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of EstradiolStatus unknownNCT03868202Phase 2
• Pessary Versus Cerclage With or Without Progesterone in TwinsTerminatedNCT03863613Not applicable
• Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin GestationStatus unknownNCT03781674Not applicable
• Effect of Cervical Cerclage With Vaginal Progesterone in Asymptomatic Twin Pregnancies With a Sonographic Short CervixStatus unknownNCT03781466Not applicable
• Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta PreviaStatus unknownNCT03779451Not applicable
• Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal WomenCompletedNCT03737656Phase 1
• Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase SupportCompletedNCT03734770Not applicable
• Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX)CompletedNCT03701490Phase 2
• Clinical Study on Endometrial ReceptivityStatus unknownNCT03687021Early Phase 1
• Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSICompletedNCT03677336Phase 4
• Progesterone in Patients With Placenta PreviaStatus unknownNCT03633175Phase 2
• Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer CyclesCompletedNCT03619707Phase 4
• Vaginal Progesterone for the Prevention of Preterm Birth in TwinsWithdrawnNCT03540225Phase 3
• Different Types of Progesterone in the Prevention of Preterm LaborStatus unknownNCT03537287Phase 2
• Progesterone Supplementation in Frozen Embryo Transfer CyclesStatus unknownNCT03504345Not applicable
• Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist ProtocolStatus unknownNCT03484611Not applicable
• The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI CyclesStatus unknownNCT03457233Not applicable
• Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With LetrozoleCompletedNCT03440359Phase 2/3
• Oral Versus Parental Progesterone in the Management of Preterm LaborCompletedNCT03343795Phase 4
• Pharmacokinetics of Progesterone in PregnancyCompletedNCT03340701Phase 1
• Endometrial Polyps Regression With Progesterone TherapyStatus unknownNCT03309709Phase 3
• Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of ProgesteroneCompletedNCT03211338Not applicable
• Vaginal Progesterone Supplementation in the Management of Preterm LaborCompletedNCT03202836Not applicable
• Study of Progesterone in Treatment of Vasomotor SymptomsTerminatedNCT03202186Phase 3
• Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI CyclesTerminatedNCT03181685Phase 4
• Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian SyndromeCompletedNCT03088046Not applicable
• Progesterone and Cervical Pessary in TwinsStatus unknownNCT03058536Phase 2/3
• Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm LaborCompletedNCT02989519Phase 3
• Progesterone in Luteal Phase DeficiencyWithdrawnNCT02950948Phase 3
• Progesterone in Threatened AbortionTerminatedNCT02950935Phase 3
• The Vaginal Progesterone and CerclageCompletedNCT02846909Phase 2
• Efficacy Study of Progesterone Tablet in Post-menopausal WomenCompletedNCT02841137Phase 2
• Subcutaneous Progesterone Supplementation in Patients With EndometriosisStatus unknownNCT02793908Phase 3
• Oral Micronized Progesterone Effects on Perimenopausal Menstrual FlowCompletedNCT02779582Phase 3
• Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer CyclesWithdrawnNCT02772120Phase 4
• Vaginal Progesterone in Twin With Short CervixCompletedNCT02697331Phase 3
• Vaginal Progesterone for Treatment of Threatened MiscarriageStatus unknownNCT02690129Not applicable
• Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTMStatus unknownNCT02673359Phase 4
• Cervical Pessary vs. Vaginal Progesterone for Preventing Premature Birth in IVF Twin PregnanciesCompletedNCT02623881Not applicable
• The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm BirthStatus unknownNCT02571296Phase 4
• Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUITerminatedNCT02510534Phase 1
• Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement TherapyCompletedNCT02467673Phase 2
• Vaginal Progesterone Versus Placebo for the Treatment of Vaginal AtrophyWithdrawnNCT02460302Phase 2
• Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term LaborCompletedNCT02430233Phase 4
• Progesterone Supplementation for HIV-positive Pregnant Women on Anti-RetroviralsStatus unknownNCT02400021Phase 2
• Lactoferrin or Progesterone for Prevention of Preterm DeliveryStatus unknownNCT02372942Phase 4
• Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes RecipientsCompletedNCT02363127Phase 4
• Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short CervixCompletedNCT02338830Phase 4
• Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short CervixTerminatedNCT02329535Not applicable
• Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase SupportCompletedNCT02316626Phase 4
• Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant WomenStatus unknownNCT02304237Phase 3
• Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older WomenCompletedNCT02272647Phase 1
• Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT TrialCompletedNCT02145767Phase 2
• A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal WomenCompletedNCT02092571Phase 1
• The Effect of Different Types of Progestin on Sleeping of Menopausal WomenCompletedNCT02086032Not applicable
• Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.CompletedNCT02032797Phase 4

← Progesterone overview